NCEL NewcelX Ltd.
Healthcare$3.27+0.00%OpenMarket Cap: $1.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.44
P/S
0.00
EV/EBITDA
0.43
DCF Value
$10.10
FCF Yield
-338.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-101.0%
ROA
-49.9%
ROIC
-142.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $0.00 | -Infinity% | $-1.8M | $-2.2M | $— | — |
| Q4 null | $0.00 | Infinity% | $-2.3M | $55.0K | $— | — |
| FY null | $0.00 | -Infinity% | $-4.4M | $-2.0M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.1M | $-2.0M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-4.3M | $-4.6K | $— | — |
| FY null | $0.00 | -Infinity% | $-11.8M | $-12.2M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-7.5M | $-7.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-6.8M | $-7.9M | $— | — |
| FY null | $0.00 | -Infinity% | $-15.5M | $-16.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-8.7M | $-8.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-7.3M | $-7.3M | $— | — |
| FY null | $0.00 | -Infinity% | $-11.9M | $-11.9M | $— | — |